SCALZO RICHARD WILLIAM (Chief Financial Officer) sold 5.2% of their position (1.11K shares) of CRESCENT BIOPHARMA, INC. on the open market
Open‑market sale worth $20.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/23/2026ACC: 0001628280-26-044890
Officer· Chief Financial Officer
Since Jun 2025
-1.11K
Net shares
Net seller
$20.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.11K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−1.11K
Price / share
$17.99
Trade value
$20K
% of position
5.2%
6/22/2026
21.41K→20.30K
Total
Net shares
−1.11K
Net value
-$20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 6/22/2026 | S · Sale | −1.11K | $17.99 | $20K | 5.2% | 21.41K | 20.30K |
| Total | −1.11K | -$20K | ||||||
Derivative Transactions0
No derivative transactions reported